Title : Appearance of an ALK mutation conferring resistance to crizotinib in non-small cell lung cancer harboring oncogenic ROS1 fusion.

Pub. Date : 2021 Mar

PMID : 33472762






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Appearance of an ALK mutation conferring resistance to crizotinib in non-small cell lung cancer harboring oncogenic ROS1 fusion. Crizotinib ROS proto-oncogene 1, receptor tyrosine kinase Homo sapiens